🇺🇸 FDA
Patent

US 9511020

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

granted A61KA61K31/573A61K45/06

Quick answer

US patent 9511020 (Controlled release corticosteroid compositions and methods for the treatment of otic disorders) held by The Regents of the University of California expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/573, A61K45/06, A61K47/10, A61K9/0046